688026 潔特生物
按盤價 
18.820 +2.310 (+13.992%) | 2026/06 - 中期 | 2025/12 | 2024/12 | 2023/12 | 2022/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 1.726 | 4.030 | 6.480 | 3.030 | 8.309 |
| 總資產報酬率 ROA (%) | 1.198 | 2.807 | 4.555 | 2.153 | 6.297 |
| 投入資產回報率 ROIC (%) | 1.289 | 3.031 | 4.895 | 2.304 | 6.918 | 邊際利潤分析 |
| 銷售毛利率 (%) | 39.405 | 41.393 | 41.413 | 30.622 | 31.842 |
| 營業利潤率 (%) | 8.641 | 11.057 | 17.137 | 8.517 | 15.757 |
| 息稅前利潤/營業總收入 (%) | 17.365 | 14.800 | 19.360 | 9.371 | 14.891 |
| 淨利潤/營業總收入 (%) | 7.943 | 8.705 | 13.679 | 7.579 | 14.380 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 83.993 | 129.381 | 107.722 | 112.525 | 102.048 |
| 價值變動淨收益/利潤總額(%) | 7.349 | 3.971 | -1.048 | -2.077 | -1.706 |
| 營業外收支淨額/利潤總額(%) | 0.158 | -2.343 | -0.123 | -2.932 | 1.954 | 償債能力分析 |
| 流動比率 (X) | 7.753 | 7.525 | 6.683 | 7.456 | 7.022 |
| 速動比率 (X) | 6.176 | 6.284 | 5.595 | 6.639 | 5.989 |
| 資產負債率 (%) | 30.283 | 29.642 | 30.092 | 28.810 | 28.979 |
| 帶息債務/全部投入資本 (%) | 23.823 | 23.452 | 22.521 | 22.565 | 21.436 |
| 股東權益/帶息債務 (%) | 312.202 | 319.544 | 335.244 | 335.003 | 357.004 |
| 股東權益/負債合計 (%) | 227.850 | 235.640 | 230.889 | 246.970 | 244.923 |
| 利息保障倍數 (X) | 1.994 | 3.704 | 8.625 | 8.550 | -12.625 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 84.846 | 103.615 | 101.819 | 90.368 | 72.624 |
| 存貨周轉天數 (天) | 157.696 | 143.409 | 117.855 | 117.256 | 107.369 |
| 備註： | 即時報價更新時間為 31/08/2026 16:29 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
